BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15551363)

  • 1. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
    Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
    Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of p57(KIP2)mRNA in human bladder cancer.
    Oya M; Schulz WA
    Br J Cancer; 2000 Sep; 83(5):626-31. PubMed ID: 10944603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome.
    John RM; Ainscough JF; Barton SC; Surani MA
    Hum Mol Genet; 2001 Jul; 10(15):1601-9. PubMed ID: 11468278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer.
    Higashimoto K; Soejima H; Saito T; Okumura K; Mukai T
    Cytogenet Genome Res; 2006; 113(1-4):306-12. PubMed ID: 16575194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.
    Arima T; Kamikihara T; Hayashida T; Kato K; Inoue T; Shirayoshi Y; Oshimura M; Soejima H; Mukai T; Wake N
    Nucleic Acids Res; 2005; 33(8):2650-60. PubMed ID: 15888726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA methylation analysis reveals that DMR-Lit1 is a putative imprinting control region.
    Yatsuki H; Joh K; Higashimoto K; Soejima H; Arai Y; Wang Y; Hatada I; Obata Y; Morisaki H; Zhang Z; Nakagawachi T; Satoh Y; Mukai T
    Genome Res; 2002 Dec; 12(12):1860-70. PubMed ID: 12466290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
    Taniguchi T; Okamoto K; Reeve AE
    Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome.
    Diaz-Meyer N; Day CD; Khatod K; Maher ER; Cooper W; Reik W; Junien C; Graham G; Algar E; Der Kaloustian VM; Higgins MJ
    J Med Genet; 2003 Nov; 40(11):797-801. PubMed ID: 14627666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CDKN1C in Beckwith Wiedemann syndrome.
    Algar E; Brickell S; Deeble G; Amor D; Smith P
    Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
    Chung WY; Yuan L; Feng L; Hensle T; Tycko B
    Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lsh controls silencing of the imprinted Cdkn1c gene.
    Fan T; Hagan JP; Kozlov SV; Stewart CL; Muegge K
    Development; 2005 Feb; 132(4):635-44. PubMed ID: 15647320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
    Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
    Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance.
    Algar EM; Deeble GJ; Smith PJ
    J Med Genet; 1999 Jul; 36(7):524-31. PubMed ID: 10424812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of KvDMR1 involved in regulating the imprinting of CDKN1C gene in cattle.
    Wang M; Li D; Zhang M; Yang W; Cui Y; Li S
    Anim Genet; 2015 Aug; 46(4):354-60. PubMed ID: 26059028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma.
    Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
    Int J Cancer; 2003 May; 104(5):568-78. PubMed ID: 12594811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.